May 4, 2026 · Form 4 insider transaction
Jerman Michael Allen bought 50,000 shares of Inhibitor Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 51 days after the transaction.
Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan.